Skip to main content
Signal8
ZASLOFF MICHAEL A profile photo

Michael A. Zasloff

CIK: 0001033511

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Amphastar Pharmaceuticals, Inc. logo
AMPH

Amphastar Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Jun 1, 2026
    Award(A)
    Direct
    8.1K shares-
  • Amphastar Pharmaceuticals, Inc. logo
    AMPH

    Amphastar Pharmaceuticals, Inc.

    Jun 2, 2025
    Award(A)
    Direct
    5.1K shares-

1-2 of 2

About ZASLOFF MICHAEL A

ZASLOFF MICHAEL A (SEC CIK 0001033511) files insider reports with the SEC as Director of Amphastar Pharmaceuticals, Inc. (AMPH).

Signal8 holds 2 ownership filings by ZASLOFF MICHAEL A, all Form 4s, filed between Jun 4, 2025 and Jun 3, 2026. Those filings report 2 transactions, from Jun 2, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ZASLOFF MICHAEL A's filings is in RANCHO CUCAMONGA, CA.

Recent filings by ZASLOFF MICHAEL A

  • Jun 1, 2026: Grant or award of AMPH shares (Form 4, code A).
  • Jun 2, 2025: Grant or award of AMPH shares (Form 4, code A).

Other insiders filing for Amphastar Pharmaceuticals, Inc. (AMPH)

How to read Form 4 transaction codes